Full Press Release Details
SEATTLE, March 02, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating virtually in the upcoming 42nd Annual Cowen Healthcare Conference.
Adaptive Biotechnologies’ management is scheduled to present on Wednesday, March 9th at 6:50 a.m. Pacific Time / 9:50 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.
About Adaptive Biotechnologies
Contact Data
Karina Calzadilla, Vice President, Investor Relations
Carrie Mendivil, Gilmartin Group
Contact
With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.